Valuation: Perrigo Company plc

Market Cap 1.4B 1.23B 1.15B 1.05B 1.98B 135B 2.01B 13.65B 5.33B 66.44B 5.27B 5.15B 230B P/E 2026 *
-72.4x
P/E 2027 * 8.74x
Enterprise Value 4.34B 3.82B 3.55B 3.26B 6.13B 416B 6.21B 42.24B 16.5B 206B 16.3B 15.95B 711B EV / Sales 2026 *
1.07x
EV / Sales 2027 * 1.03x
Free-Float
99.6%
Yield 2026 *
11.4%
Yield 2027 * 11.7%
1 day+0.41%
1 week-4.76%
Current month+0.97%
1 month+5.18%
3 months-11.56%
6 months-26.86%
Current year-24.79%
1 week 8.73
Extreme 8.73
9.33
1 month 8.51
Extreme 8.514
9.63
Current year 7.82
Extreme 7.822
13
1 year 7.82
Extreme 7.822
24.22
3 years 7.82
Extreme 7.822
36.25
5 years 7.82
Extreme 7.822
43
10 years 7.82
Extreme 7.822
88.51
Manager TitleAgeSince
Chief Executive Officer 63 2026-06-06
Director of Finance/CFO 51 2022-05-15
Chief Operating Officer - 2025-06-22
Director TitleAgeSince
Director/Board Member 75 2014-10-31
Director/Board Member 61 2016-11-06
Director/Board Member 70 2017-02-05
Change 5-day change 1-year change 3-year change Capi.($)
+0.41%-4.76% - - 1.4B
+0.13%+4.41%+47.35%+163.20% 1,067B
+0.97%+6.88%+58.02%+53.12% 635B
-0.94%+1.39%+35.02%+72.60% 458B
+1.41%+8.56%+38.93%+32.17% 347B
+1.28%+4.40%+38.42%+41.62% 295B
+1.72%+4.10%+19.31%+20.45% 262B
+1.84%-0.46%-27.78%-38.65% 216B
+0.06%+3.32%+22.73%+59.40% 203B
+0.94%-2.02%+12.32%+70.59% 161B
Average +0.78%+1.92%+27.15%+52.72% 404.83B
Weighted average by Cap. +0.60%+2.25%+36.75%+78.19%

Financials

2026 *2027 *
Net sales 4.06B 3.57B 3.32B 3.05B 5.72B 389B 5.8B 39.46B 15.41B 192B 15.23B 14.9B 664B 4.1B 3.6B 3.35B 3.08B 5.78B 393B 5.86B 39.87B 15.57B 194B 15.39B 15.05B 671B
Net income -339M -298M -277M -255M -478M -32.51B -485M -3.3B -1.29B -16.05B -1.27B -1.25B -55.48B 161M 142M 132M 121M 228M 15.48B 231M 1.57B 613M 7.64B 606M 593M 26.42B
Net Debt 2.94B 2.58B 2.41B 2.21B 4.15B 282B 4.2B 28.59B 11.17B 139B 11.03B 10.79B 481B 2.83B 2.49B 2.31B 2.13B 3.99B 271B 4.04B 27.51B 10.74B 134B 10.62B 10.39B 463B
Logo Perrigo Company plc
Perrigo Company plc is a pure-play self-care company. The Company provides health and wellness solutions. Its segments include Self Care, Specialty Care, and Infant Formula. Self Care comprises Upper Respiratory, Digestive Health, Pain & Sleep and Healthy Lifestyle product categories globally. Specialty Care comprises our Women's Health and Skin Health product categories globally. Infant Formula comprises the Infant Formula product category, which includes nutritional products designed to meet the dietary needs of infants. It provides a store-branded private label provider of self-care products in many categories, including upper respiratory, healthy lifestyle and women's health, along with brands including Opill and Mederma. Its Europe portfolio consists primarily of brands, including Compeed, ellaOne, Solpadeine, Jungle Formula, and ACO. Its upper respiratory products include Nasonex 24HR Energy, Mucus DM, All Day Allergy, Nighttime Cold & Flu, and Allergy Relief.
Employees
8,100
Date Price Change
26-07-27 €8.766 +0.41%
26-07-24 €8.730 -2.98%
26-07-23 €8.998 -3.52%
26-07-22 €9.326 +3.53%
26-07-21 €9.008 -2.13%
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
10.14USD
Average target price
16.50USD
Spread / Average Target
+62.72%

Quarterly revenue - Rate of surprise